Thomson Reuters is the world’s leading provider of intelligent information for businesses and professionals, and our Life Sciences Division supplies thousands of customers with cutting-edge technologies and comprehensive manually curated data resources. For more than 10 years, our team has been at the forefront of the systems biology industry, providing advanced bioinformatics and personalized medicine research and products to pharmaceutical companies, clinical centers and non-profit organizations globally.
We are a multi-disciplinary, diverse group of scientists who enjoy working together and with customers on developing new technologies, algorithms and solutions. We create and apply state of the art bioinformatics approaches to addressreal life challenging problems in pharmaceutical R&D, such as drug target identification, biomarker discovery, disease mechanisms understanding, patient stratification and personalized medicine. Leading technologies and creative
environment make our team the fastest growing business at Thomson Reuters Life Sciences Division and a key partner for our customers.
We are always looking for talented scientists to grow and develop our team and currently we are looking for an experienced bioinformatician who will work with our clients, from pharmaceutical companies and clinical centers as well as non-profit organizations, on advanced statistical and functional analysis of OMICs data generating hypotheses on disease mechanisms, disease and drug response biomarkers and drug targets. One of your key areas of focus will be research and development for our personalized medicine technology and solutions. In your projects, you will apply state of-the-art bioinformatics tools as well as our advanced proprietary Systems Biology
Platform; you will also develop new approaches and techniques to address complicated and interesting scientific questions, publish results of your research in scientific journals, and participate in the implementation of the approaches in working tools and commercial software. In
addition to research activities, you will also participate in business and strategy development by scoping with customers their scientific needs and transforming these needs into solutions.
Example of on-going research projects:
Drug response biomarker panel development. Development of drug response biomarkers from pre-clinical data is a critical step in drug discovery, as it enables patient stratification in clinical trials design. During the last 3 years, our team is supporting a global oncology company in identification of drug response biomarkers for anti-cancer drugs. The analysis starts with treatment data (IC50), gene expression data, and genetic data for cell lines and is aimed at the identification of
biomarkers which are then applied in clinical trials for patient stratification. Our team is responsible for the identification of gene expression and genetic biomarkers for compounds from the company’s portfolio.
Overall, our projects are focused on all stages of the drug development process. Here are some press releases describing our projects
Collaboration with Orion Bionetworks (http://thomsonreuters.com/press-releases/102013/Orion-Bionetworks)
Collaboration with NuMedii (http://thomsonreuters.com/press-releases/112013/NuMedii-Initiative)
What is in it for you?
At Thomson Reuters Systems Biology team, we believe that our scientists are our most important asset and it is our priority to make it a great place to work.
This position provides unique opportunities for further professional growth:
- enhance your vision and improve your network by working in close collaboration with diverse leading organizations, including pharmaceutical companies, clinical centers and research foundations
- gain unique expertise with internal access to vast data resources at Thomson Reuters, the largest provider of molecular and R&D information in the industry
- extend your technical skills by working in a team of bioinformaticians, biologists, chemists, knowledge management specialists and pharmaceutical industry experts with complementary skill sets to address challenges in biomarker discovery, target identification, drug repositioning, NGS data analysis, network biology and other applications
- simply enjoy being a part of a global business and a high-performing synergistic team
About Thomson Reuters
Thomson Reuters employees take pride in providing our customers around the world with information that is timely, accurate, unbiased and trusted. We have a profound respect for the professions and customers we serve and define our success in terms of their success. Our work environment is dynamic, innovative and entrepreneurial. We have a result oriented culture that demands excellence, agility, and the desire to move quickly and precisely to seize opportunities. Our environment is both challenging and supportive - we give employees the opportunity to develop their skills and do their best work.